Loading Complete
Sanjay K. Jain

Sanjay K. Jain, MBBS

Pediatric Infectious Diseases

Highlights

Age Groups Seen

  • Infant 0-2
  • Child 3-12
  • Adolescent 13-17

Languages

  • Hindi
  • English

Gender

Male

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Sanjay K. Jain

Professional Titles

  • Director, Center for Infection and Inflammation Imaging Research
  • Vice Chair for Basic & Translational Research, Department of Pediatrics

Primary Academic Title

Adjunct Professor of Pediatrics

Independent Clinician

Logo for Independent Clinician

Background

Dr. Sanjay Kumar Jain is a Professor of Pediatrics, Radiology and Radiological Science. He is also a Professor of International Health at the Bloomberg School of Public Health. His areas of clinical expertise include pediatric infectious diseases, tuberculosis / mycobacterial infections, and international health.

Dr. Jain serves as the director of the Center for Infection and Inflammation Imaging Research and is a member of the Center for TB Research at Johns Hopkins. He is also the Vice Chair for Basic & Translational Research for the Department of Pediatrics and the principal investigator for the Pediatric Infectious Diseases NIH T32 award that supports the fellowship program. 

Born in Halifax, Canada, Dr. Jain grew up in India. He received his medical degree in 1999 from All India Institute of Medical Sciences in New Delhi, where he was a house officer in neuroradiology. He trained in pediatrics at Penn State Children’s Hospital, Milton S. Hershey Medical Center, and the Tufts University School of Medicine. He was a clinical fellow in pediatric infectious diseases at Johns Hopkins before joining its faculty in 2005. Dr. Jain was named an associate professor of pediatrics in 2011 and professor of pediatrics, radiology and radiological science in 2017.

The major focus of Dr. Jain’s research is on pathogenesis of infections, with a special emphasis on bacteria and high-containment pathogens such as Mycobacterium tuberculosis (causative agent of tuberculosis) and recently SARS-CoV-2. Dr. Jain’s laboratory utilizes small animal models and cutting-edge molecular imaging technologies to develop and test novel radiopharmaceutical imaging methods (CT, PET, SPECT, MRI) to study disease pathogenesis as well as to develop precision medicine tools for the diagnosis and monitoring of infections. They have the unique capacity to image animals infected with high-containment pathogens (up to biosafety level-3). Several novel tracers developed in his laboratory are now being tested in first-in-human studies. Dr. Jain is also involved with developing innovative technologies to improve childhood immunizations and health of young children in the developing world.

Dr. Jain is funded through several NIH and other grants. Notably, he is also the recipient of the prestigious NIH Director’s New Innovator Award (2009) and the NIH Director’s Transformative Research Award (2014). Dr. Jain is the founding member and past chair of the Infectious Diseases subgroup and current board member of the World Molecular Imaging Society. He serves as a reviewer for multiple scientific journals and NIH study panels.

Centers and Institutes

Find a Clinical Trial

View all trials by this principal investigator.

Research Interests

Cellular and low-cost technologies to improve health care, CNS tuberculosis, Imaging for infections and inflammatory diseases, Mycobacteria, Pediatric tuberculosis, Tuberculosis

Lab Website

Center for Infection and Inflammation Imaging Research - Lab Website

  • In conjunction with the Molecular Imaging Center, the Center for Infection and Inflammation Imaging Research core provides state-of-the art small animal imaging equipment, including PET, SPECT, CT and US, to support the wide range of scientific projects within the diverse research community of the Johns Hopkins University and beyond. Trained technologists assist investigators in the use of these facilities.

Core Facility

Infection and Inflammation Imaging Research at the Division of Infectious Diseases (Ci3R), Center for

Patents

  • Radiolabeled PABA and derivatives thereof for use as functional renal imaging agents, US Patent Application Number 62/729,876
  • Mycobacterial polypeptide for use in producing vaccine to prevent grampositive bacterial infection, PCT/US2008/0241182 A1
  • Bacteria-specific labeled substrates as Imaging biomarkers to diagnose, locate and monitor infections, PCT/US2013/059897

Honors

  • Transformative Research Award, National Institutes of Health, 1/1/14
  • NIH Director's New Innovator Award, National Institutes of Health, 1/1/09
  • Named Marylands Innovator of the Year, The Daily Record, 1/1/08
  • Named amongst Americas Best and the Brightest in the Arts, Sciences and Social change, The Genius Issue & Innovators, Esquire Magazine, 1/1/07
  • Program Choice Award, IDSA, 1/1/05
  • Pediatric Infectious Diseases Society Award, IDSA, 1/1/05
  • Clinician Scientist Award, Johns Hopkins University, 1/1/05

Graduate Program Affiliations

  • Pathobiology

Expertise

Education

  • All India Institute of Medicine Sciences, M.B.B.S., 1999